Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
African Journal of Primary Health Care & Family Medicine|November 6, 2024
A blended teaching and learning model for family-medicine registrar training at a South African universityAnn Z George, Carien Lion-Cachet, Michele Torlutter, et al.
Diagnostic and Interventional Imaging|March 13, 2014
Establishment of a consultation to announce the results of a breast biopsyM Boisserie-Lacroix, O Duguey-Cachet, N Stadelmaier, et al.
Journal of Hospice and Palliative Nursing : JHPN : the Official Journal of the Hospice and Palliative Nurses Association|February 25, 2022
Supporting Family Members in Palliative Phases of Cancer: A Qualitative Study Comparing Health Care Professionals and Non-Health Care ProfessionalsNena Stadelmaier, Laura Assemat, Bernard Paternostre, et al.
Nephron|February 6, 2022
Warfarin Use, Stroke, and Bleeding Risk among Pre-Existing Atrial Fibrillation US Veterans Transitioning to DialysisJohn Sy, Cachet Wenziger, Maria Marroquin, et al.
Natural Product Research|February 11, 2015
A new 3,4-seco-cycloartane from the leaves of Hopea odorata RoxbMalai Satiraphan, Quoc Dang Thai, Uthai Sotanaphun, et al.
Bioorganic & Medicinal Chemistry|May 3, 2005
New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluationChristine Borrel, Sylviane Thoret, Xavier Cachet, et al.
Frontiers in Chemistry|August 28, 2020
Mesopore Formation and Silicon Surface Nanostructuration by Metal-Assisted Chemical Etching With Silver NanoparticlesElisa Pinna, Sylvain Le Gall, Encarnacion Torralba, et al.
Journal of Natural Products|July 10, 2010
Antiprotozoal steroidal saponins from the marine sponge Pandaros acanthifoliumErik L Regalado, Deniz Tasdemir, Marcel Kaiser, et al.
Current Medicinal Chemistry|June 10, 2011
Biological potential and structure-activity relationships of most recently developed vascular disrupting agents: an overview of new derivatives of natural combretastatin a-4M Marrelli, F Conforti, G A Statti, et al.
Drugs|December 16, 2021
Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19John G Rizk, Cachet Wenziger, Diana Tran, et al.
Pageof 9